KM
PVCT

Kalos Management’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Kalos Management’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed – – 316
2021
Q1 		$0 Buy
+10,000
New – ﹤0.01% 330

Other funds holding PVCT

HFBOT
Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
ACM
Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Kalos Management's PVCT Position: Q2 2021 in Review

Kalos Management sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q2 2021, closing a stake of 10,000 shares.

Kalos Management first reported a position in PVCT in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 7 funds tracked by Wall St. Rank hold PVCT as of Q2 2021.

  • Kalos Management reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q2 2021 after selling out during the quarter.
  • Kalos Management sold 10,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q2 2021.
  • Kalos Management first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q1 2021 and held it in 1 quarter.
  • Kalos Management's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $0 in Q1 2021.
  • 7 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q2 2021.

Based on Kalos Management's 13F filing for Q2 2021, filed 11 Aug 2021.